Literature DB >> 23040431

Rare variants in GJA5 are associated with early-onset lone atrial fibrillation.

Ingrid E Christophersen1, Haya N Holmegard, Javad Jabbari, Ahmad Sajadieh, Stig Haunsø, Arnljot Tveit, Jesper H Svendsen, Morten S Olesen.   

Abstract

BACKGROUND: Genetic factors are believed to be important in early-onset lone atrial fibrillation (AF). The gene GJA5 encodes the gap-junction protein Cx40, which together with Cx43 is responsible for the electrical coupling of the atrial cardiomyocytes. The regulatory single nucleotide polymorphism rs10465885 in GJA5 was recently associated with early-onset lone AF (< 60 years) and was also found to be strongly associated with Cx40 messenger RNA levels. We hypothesized that this gene would have a strong effect in patients with a more selected phenotype, and that the findings regarding rs10465885 could be replicated in this group.
METHODS: The coding region and flanking intron sequences of GJA5 were resequenced in 342 patients with onset of lone AF before the age of 50 (mean age at onset 34 ± 9 years), and in 216 controls. The single nucleotide polymorphism rs10465885 was genotyped in 342 patients and 534 control subjects and odds ratios were calculated for different genetic models.
RESULTS: Genotyping of rs10465885 showed that the patients with early-onset lone AF were more likely to carry the A allele compared with controls (odds ratio = 1.30; P = 0.011). When resequencing GJA5, we identified the mutation A96S, previously associated with lone AF, which was not present in our control subjects or in any publicly available database or the National Heart, Lung, and Blood Institute Exome Variant Server (NHLBI EVS; 10,758 alleles).
CONCLUSIONS: We show a highly significant association between the A allele of rs10465885 and onset of lone AF before age 50. This opposes a previous study, wherein the G allele was found to be associated with AF, and makes it impossible to exclude that the associations are coincidental.
Copyright © 2013 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23040431     DOI: 10.1016/j.cjca.2012.08.002

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  23 in total

Review 1.  Emerging directions in the genetics of atrial fibrillation.

Authors:  Nathan R Tucker; Patrick T Ellinor
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 2.  The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics: Is Personalized Therapy in Sight?

Authors:  Dawood Darbar
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

Review 3.  Genetics of atrial fibrillation: from families to genomes.

Authors:  Ingrid E Christophersen; Patrick T Ellinor
Journal:  J Hum Genet       Date:  2015-05-21       Impact factor: 3.172

Review 4.  Atrial fibrillation: the role of common and rare genetic variants.

Authors:  Morten S Olesen; Morten W Nielsen; Stig Haunsø; Jesper H Svendsen
Journal:  Eur J Hum Genet       Date:  2013-07-10       Impact factor: 4.246

5.  Association of atrial fibrillation with gene polymorphisms of connexin 40 and angiotensin II receptor type 1 in Chongming adults of Shanghai.

Authors:  Shuxin Hou; Yingmin Lu; Damin Huang; Xiaohan Luo; Dongmei Yue; Jinchun Zhang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 6.  Genomics of Atrial Fibrillation.

Authors:  Alejandra Gutierrez; Mina K Chung
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

Review 7.  Genetic mechanisms of atrial fibrillation: impact on response to treatment.

Authors:  Dawood Darbar; Dan M Roden
Journal:  Nat Rev Cardiol       Date:  2013-04-16       Impact factor: 32.419

Review 8.  Atrial Fibrillation Genetics: Is There a Practical Clinical Value Now or in the Future?

Authors:  William J Hucker; Harsimran Saini; Steven A Lubitz; Patrick T Ellinor
Journal:  Can J Cardiol       Date:  2016-02-12       Impact factor: 5.223

9.  Connexin40 abnormalities and atrial fibrillation in the human heart.

Authors:  Joanna Gemel; Andrew E Levy; Adria R Simon; Katherine B Bennett; Xun Ai; Shahab Akhter; Eric C Beyer
Journal:  J Mol Cell Cardiol       Date:  2014-09-06       Impact factor: 5.000

10.  Genetic Discoveries in Atrial Fibrillation and Implications for Clinical Practice.

Authors:  Saagar Mahida
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.